Longqin Hu

17PUBLICATIONS
14CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsToxicology (incl. clinical toxicology)Organometallic chemistryBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 25, 2026
Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD).

|Aug 18, 2026
Zidesamtinib (Jideytro®): a new selective, brain-penetrant ROS1 inhibitor approved for the treatment of ROS1-positive non-small cell lung cancer.

|Aug 07, 2026
From propofol to cipepofol (Cypsedo®), a new intravenous general anesthetic approved for adults undergoing surgery.

|Apr 07, 2026
N-Mesyl-Enabled Cu2O Catalysis: Synthesis of (E)-3-Alkylideneisoindolin-1-ones and 3,4-Unsubstituted Isoquinolones via Sequential Alkynylation/Annulation.

Ahmed R Ali, Longqin Hu

|Feb 06, 2026
Design and optimisation of meta-substituted bis(arylsulfonamido)benzene inhibitors through a molecular hybridisation strategy targeting the Keap1-Nrf2 protein-protein interaction.

Sumi Lee, Ahmed R Ali, Dhulfiqar Ali Abed

|Aug 05, 2025
Cu2O-mediated regio- and stereoselective one-pot synthesis of (Z)-3-ylidenephthalides from 2-iodobenzoic acids and terminal alkynes.

Ahmed R Ali, Longqin Hu

Pageof 3

Frequent Collaborators

5 joint publications

Michael D Ward

4 joint publications

Jeffrey Yang

4 joint publications

Ahmed R Ali

2 joint publications

Sumi Lee